Suppr超能文献

[人内皮抑素基因的克隆、表达及其对胶质瘤体内抑制作用的研究]

[Research of cloning, expression of human endostatin gene and its inhibition effects to the glioma in vivo].

作者信息

Zhang X, Wu J, Fei Z

机构信息

Institute of Neurosurgery of PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2001 Jul 10;81(13):783-7.

Abstract

OBJECTIVE

To clone human endostatin gene, detect its biological activities of endostatin protein and use it to cure human SHG44 gliomas of nude mice in vivo.

METHODS

The mRNA from the human liver tissue was extracted. And the functional fragment of endostatin gene was amplified by RT-PCR. It was cloned into pUC19 and sequenced according to Dye primer sequencing kit. The non-fusion expression vector pDH-endo was constructed. The recombinant human endostatin gene was expressed in DH5alphaat the condition of temperature induction. The protein activities were tested by Chicken Chorio-Allantoic Membrane (CAM) assay and endothelial cell proliferation inhibitory assay. Endostatin protein was applied to the nude mice through hypodermic injection in order to cure the SHG44 glioma.

RESULTS

The acquired endostatin gene is 551 bp, its sequence is correct and the expressed protein is 20 kDa. The protein possesses the anti-angiogenesis activity. Hypodermic injection of endostatin at the dose of 5 mg/kg/d, 10 mg/kg/d or 20 mg/kg/d can inhibit the human glioma angiogenesis and tumor growth(the inhibition rate of the tumor are seperately 34.5%, 76.1% and 80.2%).

CONCLUSION

The cloning, expression and preliminary application of human endostatin protein lay the foundation for the antiangiogenesis therapy of glioma and the other solid tumors.

摘要

目的

克隆人内皮抑素基因,检测其内皮抑素蛋白的生物学活性,并在体内用于治疗人裸鼠SHG44胶质瘤。

方法

提取人肝组织中的mRNA。通过RT-PCR扩增内皮抑素基因的功能片段。将其克隆到pUC19中,并根据染料引物测序试剂盒进行测序。构建非融合表达载体pDH-endo。重组人内皮抑素基因在温度诱导条件下在DH5α中表达。通过鸡胚绒毛尿囊膜(CAM)试验和内皮细胞增殖抑制试验检测蛋白活性。通过皮下注射将内皮抑素蛋白应用于裸鼠以治疗SHG44胶质瘤。

结果

获得的内皮抑素基因长551 bp,其序列正确,表达的蛋白为20 kDa。该蛋白具有抗血管生成活性。以5 mg/kg/d、10 mg/kg/d或20 mg/kg/d的剂量皮下注射内皮抑素可抑制人胶质瘤血管生成和肿瘤生长(肿瘤抑制率分别为34.5%、76.1%和80.2%)。

结论

人内皮抑素蛋白的克隆、表达及初步应用为胶质瘤及其他实体瘤的抗血管生成治疗奠定了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验